Hypertryptasemia and mast cell-related disorders in severe osteoporotic patients: Mediators of Inflammation

G. Carosi, G. Guabello, M. Longhi, F. Grifoni, E. Passeri, S. Corbetta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number5785378
JournalMediators Inflamm.
Volume2020
DOIs
Publication statusPublished - 2020

Keywords

  • 25 hydroxyvitamin D
  • alendronic acid
  • alkaline phosphatase
  • calcium
  • CD2 antigen
  • denosumab
  • interleukin 2 receptor alpha
  • parathyroid hormone
  • parathyroid hormone[1-34]
  • phosphate
  • risedronic acid
  • tryptase
  • abnormally high substrate concentration in blood
  • adult
  • aged
  • alkaline phosphatase blood level
  • Article
  • biochemical analysis
  • bone density
  • bone fragility
  • bone metabolism
  • calcium blood level
  • calcium metabolism
  • clinical outcome
  • disease association
  • disease severity
  • dual energy X ray absorptiometry
  • female
  • fragility fracture
  • genotype
  • human
  • hypertryptasemia
  • immunohistochemistry
  • major clinical study
  • male
  • middle aged
  • oncogene c kit
  • osteoporosis
  • parathyroid hormone blood level
  • phosphate blood level
  • polycythemia vera
  • predictive value
  • prevalence
  • protein blood level
  • restriction fragment length polymorphism
  • reverse transcription polymerase chain reaction
  • Sanger sequencing
  • sensitivity and sensibility
  • spine fracture
  • systemic mastocytosis
  • vitamin blood level

Cite this